| P50 | author | Melvin Khee-Shing Leow | Q46629520 |
| P2093 | author name string | Yong Howe Ho | |
| | Yingshan Lee | |
| | Leon Yuan Rui Tan | |
| P2860 | cites work | Interest of systematic screening of pheochromocytoma in patients with neurofibromatosis type 1. | Q49160970 |
| | Circumstances of discovery of phaeochromocytoma: a retrospective study of 41 consecutive patients. | Q53623621 |
| | Neurofibromatosis type 1 (NF1) and pheochromocytoma: prevalence, clinical and cardiovascular aspects | Q60808163 |
| | Life expectancy, mortality and prognostic factors in neurofibromatosis type 1. A twelve-year follow-up of an epidemiological study in Göteborg, Sweden | Q71856517 |
| | Changes in clinical features and long-term prognosis in patients with pheochromocytoma | Q73456675 |
| | Renovascular disease and hypertension in children with neurofibromatosis | Q74216658 |
| | Clinical and genetic characteristics of patients with neurofibromatosis type 1 and pheochromocytoma | Q79766897 |
| | Clinical experience with pheochromocytoma in a single centre over 16 years | Q85926457 |
| | Pheochromocytoma in Neurofibromatosis Type 1: When Should it Be Suspected? | Q87273529 |
| | Mortality associated with neurofibromatosis 1: a cohort study of 1895 patients in 1980-2006 in France | Q21202873 |
| | Insights into the pathogenesis of neurofibromatosis 1 vasculopathy | Q28141749 |
| | Mortality associated with neurofibromatosis type 1: a study based on Italian death certificates (1995-2006) | Q30475780 |
| | Clinical manifestations and management of neurofibromatosis type 1. | Q31047816 |
| | von Recklinghausen's disease and pheochromocytomas | Q33753382 |
| | Mortality in neurofibromatosis 1: an analysis using U.S. death certificates. | Q34020644 |
| | Guidelines for diagnosis and therapy of MEN type 1 and type 2. | Q34104591 |
| | Evaluation and management of hypertension in childhood | Q34164774 |
| | Cardiovascular disease in neurofibromatosis 1: report of the NF1 Cardiovascular Task Force | Q34785638 |
| | Long-term effect of specific treatment of primary aldosteronism on carotid intima-media thickness | Q35161719 |
| | Guidelines for the diagnosis and management of individuals with neurofibromatosis 1 | Q36653938 |
| | Vascular abnormalities in patients with neurofibromatosis syndrome type I: clinical spectrum, management, and results | Q36903322 |
| | Health supervision for children with neurofibromatosis | Q37098267 |
| | Neurofibromatosis type 1 revisited | Q37360771 |
| | Von Hippel-Lindau disease (vHL). National clinical guideline for diagnosis and surveillance in Denmark. 3rd edition | Q38172706 |
| | Pheochromocytomas are diagnosed incidentally and at older age in neurofibromatosis type 1. | Q38992673 |
| | Von Recklinghausen neurofibromatosis | Q40262766 |
| | Clinical experience over 48 years with pheochromocytoma | Q40810053 |
| | Increased Risk of Cerebrovascular Disease Among Patients With Neurofibromatosis Type 1: Population-Based Approach | Q41067746 |
| | Pheochromocytoma in Italy: a multicentric retrospective study | Q42481322 |
| | Multiple catecholamine-secreting paragangliomas: diagnosis after hemorrhagic stroke in a young woman | Q46607520 |
| | Carotid vascular remodeling in patients with pheochromocytoma | Q46955977 |
| | High incidence of cardiovascular complications in pheochromocytoma. | Q47880260 |
| | Hypertension in children with neurofibromatosis. | Q48130200 |
| | Pheochromocytoma and paraganglioma in patients with neurofibromatosis type 1. | Q49156644 |
| P577 | publication date | 2017-11-03 | |
| P1433 | published in | BMJ case reports | Q27723081 |
| P1476 | title | Giant phaeochromocytoma presenting with an acute stroke: reappraising phaeochromocytoma surveillance for the neurofibromatosis type 1 phakomatosis | |
| P478 | volume | 2017 | |